The Inaugural MedFemTech Congress

Palais des Congres, Paris, France | May 9-10, 2023

Promoting emerging medical solutions for women to improve diagnostics and treatment

Founding Partners

Knowledge Partner

MedFemTech Congress

The inaugural MedFemTech Congress will connect and engage key players in the female medical technology sector, launching a global community of medical professionals, tech visionaries, innovators, investors and other experts from across the health care ecosystem – representing doctors, hospitals, clinics, academia, venture capital firms and technology solution companies.

The overall fem-tech market was valued at $18.7B in 2019 and is projected to reach $60.1B by 2027, with a CAGR of over 15.6%. The industry value remains underestimated.

Over 1,500 companies have been classified as med-fem-tech, categorized into 14 subsectors and 8 aggregated subsectors by application. Of the total market, pregnancy is the largest one.

The inaugural congress will offer a 2-day scientific program focusing on the main medical challenges facing women, primarily highlighting the following topics:

Maternal health, prenatal care and breastfeeding
Menstrual health
Pelvic, sexual organ and other gynecological cancers
Reproductive health, assisted reproduction technologies
Endometriosis, pelvic floor and sexual health
Women’s cancer: breast cancer and reconstruction, ovarian cancer and cervical cancer
Menopause and peri- and post-menopausal symptoms
Contraception: oral contraceptives and IUDs
Gynecological infections: bacterial vaginosis, HPV and sexually transmitted diseases
Longevity
Diagnostics
Artificial intelligence (AI) for women’s health
Advanced medicine for women

Each topic will be headlined by a medical presentation and followed by 5-10 brief “lightning talks” by start-ups focusing on their relevant innovation.

The congress will host 50-100 exhibitors with a focus on start-up companies and will offer unique networking opportunities and individual meetings among investors, industry professionals and start-ups.

Forbes “spotlight” articles will provide global exposure for top selected start-ups presented throughout the congress.

We hope to see you in Paris in May 2023 for this innovative event!

Get in touch

MedFemTech Mobile App

To get the most of the the congress, we recommend downloading the event app. We are sure you’ll have a successful event by connecting with other attendees and making sure you don’t miss any session or speakers.

Open event app

Get the mobile app

Download the app to benefit from all features. Login with the email address you used to register to the event to get access to The Inaugural MedFemTech Congress.

Tailored Package for Start-up Companies

Download the prospectus

$25.1B

Market today

$60.1B

Market projection by 2027

1,500

Start-up companies

Our Unique Structure & Program

Download the Program

Our unique program structure composed of:

2 day scientific program focusing on the main medical challenges facing women

Each topic headlines by a medical presentation and followed by 5-10 brief ‘lighting talks’ of start-ups focusing in this area

50-100 exhibitors with focus on start-up companies

Networking & individual meetings between investors/industry and start ups

Global exposure via Forbes ‘spotlight’ interview for selected top ~10 start-ups

An extensive participant directory

Download the Program

Founding Members

Prof. Zeev Shoham (IVF-Worldwide)
Prof. Milton Leong (IVF-Worldwide)
Prof. Ran Balicer (Chief Innovation Officer, Clalit Health Services, IL)
Mr. Dominique Busso (Forbes)
Ms. Gila Tolub (McKinsey & Company)
Ms. Marie Busson (McKinsey & Company)
Tiffany Starr McKever (Founder and Chief Strategist, Consensus Healthcare Consultants)

Advisory Board

Maura Rosenfeld, MindUP
Marija Butkovic, Women of Wearables
Navneet Kaur, FemTech India
Reenita Das, Frost & Sullivan

Scientific and Medical Board

Prof. Yesha Sivan, DigitalRosh
Itamar Netzer, MD MBA, OB/GYN, Medical Administration specialist, Clalit
Dr. Stasa Stankovic, University of Cambridge
Noemie Elhadad, PhD, Columbia University
Prof. Jennifer Garrison
Prof. Antonio Pellicer, the ‘IVI Foundation’ and ‘Equipo IVI’
Prof. Gerald Schatten, Pittsburgh Development Center